Should we be supporting BullChina's educational-military degree?
His profile states he's from North Korea...aren't they communists?
I do agree, but with biotechs, if you miss the good news, you missed the score. Look at Intercept and Intermune. Still great companies but the 6-10 bagger moves are well behind it.
I would personally watch PACB (following ILMN's path), MACK and NVAX. These companies are going to be the future mover and shakers of biotechs.
I personally like INO as well but it's more of a gamble, at least right now.
Exception? What exception.
I could name around 50 biotechs that were about $1-$2 that are well over $50-$100 around 3-5 years later.
Even monster Illumnia came up from the ashes around $1.40 about ten years ago.
"What I have learned is that pharma stocks are not a long term hold in stage1 or stage 2"
Clearly you haven't learned too well. Pharmacyclics ran from about $1.30 to $140 in about 2.5 years. Guess ya missed that one eh? Luckily I rode the tide since $19.
I suppose it was a good lesson to be learned while I was 19-20 years old and a college student (I was born in 1980), than it would be making the same mistake if I were 40 or older.
Granted my portfolio was toasted then but I came out even better by changing my investment strategy.
Ditto - Same thing here with young Internet stocks here. I was trading in/out while the Internet stocks were imploding (1999-2000). My portfolio eventually hit ZERO after about 12-18/months.
I then invested differently in the Internet-crash another way by acquiring tons and tons of virtual real estate that was selling for mere pennies on the dollar. Fast forward more than 14 years and the Internet business/sector is monster business and I'm the CEO of a virtual real estate company with one employee (myself) that generates around 750-1m annually.
Sometimes you learn from your mistakes by looking at the same glass differently than you previously did.
Might take some time, but I tend to agree. Long-term strategy looks very nice. Still a young company, but I see it definitely taking out the $1 range, then slowly heading north from there over coming months/years.
My investment is purely a long-term play here. Consider my 120k shares locked up and out of traders hands.
Order grabbed 1000 real fast, then stalled forever, then grabbed the 39,000/more shares.
You could see my order fulfilled on the intraday chart totaling 40k.
Order took over 10min to fill and I placed a price slightly above the current market price.
Any idea what the huge lag in finding shares? I didn't even do a all-or-nothing trade.
Shorting here might limit your gains to be honest. I know the recent news has been grim lately, but how much more can gravity give? This stock is already down roughly 60%...unless you see $1 or $2 coming, be my guest and short here.
It's bound to continue falling hard or slowly creep higher. The days of GALE's rapid gains are in the history books. Unless NeuVax actually works...the days of the rapid gains probably will not be coming back.
Shorts only have to cover when the company gets all outstanding shares acquired by another company.
Shorts do not have to cover when the company goes bankrupt.
Longs are hoping this hits $10, shorts are hoping this hits $0.
No matter how you splice it, it's an investment on both sides of the table.
You are not required to read the articles they publish. For all you know, he might have 1-3 readers whom of which are being handsomely rewarded for being on the short end.
Who cares if he went long of short at the time of his article. He's only a freelance writer, not directly employed by SA...Doesn't this entitle him to his personal opinion and investing decision?
...Because this company is totally a house of card waiting for collapse.
Once Neuvax fails badly, I would hate to be a shareholder that loses 70% of the portfolio messing with this scam of a company. Knowing GALE shareholders here (I used to be one as well), somehow I find it easy to believe that if this were to fall 70% in one trading day....these crazy longs here would still find a positive spin on the news.
If the management doesn't believe in GALE, then why should you? It's called insider trading for a reason. Your trading is simply speculative investing or gambling here.
Insiders sold out around $5.40-$5.60, then got it right.
At least someone is making money here, albeit the insiders.
I couldn't agree more.
Start-up companies similar to MACK are paying their execs high 6 or low 7 figures with nothing approved. Such a waste of good cash flow.
You have to remember bro that this is a clinical-stage pharmaceutical company. There are no approved products and no steady incoming revenue (besides the partnership/licensing revenue - which is not constant, varies on clinical trials, results, milestones, etc).
The entire executive team here is only pulling in between 260-475k each. Sure this is a nice amount compared to your typical worker at Target, Home Depot clerk or bank teller. This is however not a huge amount for a company that, like any other pharma/biotech out there, has the possibility in slow down or cure cancer.
It's best to have their options elevated to ensure they are performing atop of their game. At the same time, by not paying themselves $1/million annual in base salary, they aren't blowing the shareholders money (cash burn rate) or risk diluting the stock by issuing additional shares.
I'm in complete agreement with their current compensation salary/options package. You should as well because it's by all means, very, very moderate.
Also confirmed on NASD, Yahoo and Scottrade.
Very small volume though, but why would anymore pay $5.74 AH when it closed at $5.53.
The 8200 @ $5.40 was a regular day print trade so disregard this AH trade.